Dimensional Fund Advisors
SGMO

Dimensional Fund Advisors’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Dimensional Fund Advisors’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-80,584
Closed -$52.8K – 3325
2025
Q1 		$52.8K Sell
80,584
-3,686
-4% -$3.9K ﹤0.01% 3255
2024
Q4 		$86K Sell
84,270
-409,416
-83% -$748K ﹤0.01% 3254
2024
Q3 		$428K Sell
493,686
-24,517
-5% -$18K ﹤0.01% 3062
2024
Q2 		$186K Sell
518,203
-34,676
-6% -$18.7K ﹤0.01% 3177
2024
Q1 		$371K Sell
552,879
-22,186
-4% -$16.1K ﹤0.01% 3096
2023
Q4 		$313K Sell
575,065
-228,826
-28% -$105K ﹤0.01% 3125
2023
Q3 		$482K Sell
803,891
-737,729
-48% -$790K ﹤0.01% 3048
2023
Q2 		$2M Sell
1,541,620
-1,761,737
-53% -$2.41M ﹤0.01% 2783
2023
Q1 		$5.81M Sell
3,303,357
-140,926
-4% -$402K ﹤0.01% 2433
2022
Q4 		$10.8K Buy
3,444,283
+373,442
+12% +$1.45M ﹤0.01% 2169
2022
Q3 		$15M Sell
3,070,841
-12,786
-0.4% -$65.7K 0.01% 1968
2022
Q2 		$12.8M Buy
3,083,627
+242,734
+9% +$1.05M ﹤0.01% 2094
2022
Q1 		$16.5M Buy
2,840,893
+614,426
+28% +$3.65M 0.01% 2069
2021
Q4 		$16.7M Sell
2,226,467
-89,740
-4% -$780K 0.01% 2081
2021
Q3 		$20.9M Sell
2,316,207
-690,271
-23% -$6.82M 0.01% 1980
2021
Q2 		$36M Buy
3,006,478
+351,101
+13% +$3.98M 0.01% 1696
2021
Q1 		$33.3M Buy
2,655,377
+299,322
+13% +$4.03M 0.01% 1731
2020
Q4 		$36.8M Buy
2,356,055
+62,257
+3% +$729K 0.01% 1611
2020
Q3 		$21.7M Buy
2,293,798
+35,910
+2% +$388K 0.01% 1806
2020
Q2 		$20.2M Buy
2,257,888
+60,953
+3% +$565K 0.01% 1867
2020
Q1 		$14M Buy
2,196,935
+12,353
+0.6% +$91.7K 0.01% 1943
2019
Q4 		$18.3M Buy
2,184,582
+60,398
+3% +$555K 0.01% 2085
2019
Q3 		$19.2M Buy
2,124,184
+165,780
+8% +$1.86M 0.01% 2040
2019
Q2 		$21.1M Buy
1,958,404
+441,744
+29% +$4.7M 0.01% 2014
2019
Q1 		$14.5M Buy
1,516,660
+277,550
+22% +$2.83M 0.01% 2227
2018
Q4 		$14.2M Buy
1,239,110
+1,017,573
+459% +$12.6M 0.01% 2173
2018
Q3 		$3.75M Buy
+221,537
New +$3.37M ﹤0.01% 2768
2018
Q2 		– Sell
-230,252
Closed -$4.38M – 3377
2018
Q1 		$4.38M Hold
230,252
– – ﹤0.01% 2675
2017
Q4 		$3.78M Sell
230,252
-3,500
-1% -$52.1K ﹤0.01% 2707
2017
Q3 		$3.51M Hold
233,752
– – ﹤0.01% 2702
2017
Q2 		$2.06M Buy
233,752
+104,988
+82% +$674K ﹤0.01% 2841
2017
Q1 		$670K Buy
128,764
+513
+0.4% +$2.06K ﹤0.01% 3051
2016
Q4 		$391K Buy
128,251
+10,877
+9% +$39.6K ﹤0.01% 3129
2016
Q3 		$543K Buy
117,374
+6,200
+6% +$31.5K ﹤0.01% 3054
2016
Q2 		$644K Buy
111,174
+11,964
+12% +$76.3K ﹤0.01% 3008
2016
Q1 		$600K Buy
+99,210
New +$596K ﹤0.01% 3017
2015
Q1 		– Sell
-1,178
Closed -$18K – 3387
2014
Q4 		$18K Hold
1,178
– – ﹤0.01% 3426
2014
Q3 		$13K Sell
1,178
-106,653
-99% -$1.39M ﹤0.01% 3468
2014
Q2 		$1.65M Sell
107,831
-3,900
-3% -$56.1K ﹤0.01% 2914
2014
Q1 		$2.02M Buy
111,731
+478
+0.4% +$9.21K ﹤0.01% 2834
2013
Q4 		$1.54M Sell
111,253
-140,029
-56% -$1.61M ﹤0.01% 2918
2013
Q3 		$2.63M Sell
251,282
-166,266
-40% -$1.65M ﹤0.01% 2771
2013
Q2 		$3.26M Buy
+417,548
New +$3.64M ﹤0.01% 2666

Other funds holding SGMO

YAG
Yorkville Advisors Global Mountainside, New Jersey $155M AUM 58.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Dimensional Fund Advisors's SGMO Position: Q2 2025 in Review

Dimensional Fund Advisors sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2025, closing a stake of 80,584 shares — an estimated $52.8K sold.

Dimensional Fund Advisors first reported a position in SGMO in Q2 2013 and held it in 43 quarters. The position peaked at $36.8M in Q4 2020. 114 funds tracked by Wall St. Rank hold SGMO as of Q2 2025.

  • Dimensional Fund Advisors reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2025 after selling out during the quarter.
  • Dimensional Fund Advisors sold 80,584 SANGAMO THERAPEUTICS INC shares in Q2 2025, an estimated $52.8K.
  • Dimensional Fund Advisors first reported a position in SANGAMO THERAPEUTICS INC in Q2 2013 and held it in 43 quarters.
  • Dimensional Fund Advisors's SANGAMO THERAPEUTICS INC position peaked at $36.8M in Q4 2020.
  • 114 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2025.

Based on Dimensional Fund Advisors's 13F filing for Q2 2025, filed 12 Aug 2025.